Mastaplex Limited Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2013

Location

New Zealand

Primary Industry

Agribusiness

About

Based in New Zealand, and founded in 2013, Mastaplex Limited operates as a veterinary diagnostics company. The company was founded by its CEO Olaf Bork. In July 2022, Mastaplex raised USD 0.70 million in venture funding from unspecified investors. Mastaplex product line includes Mastatest, which is a point-of-care on-farm mastitis diagnostic tool that consists of cartridges, Lapbox, and a console that is used by veterinarians to diagnose bovine mastitis. The company offers a patented technology that identifies bacterial strains in cows in three different processes: loading a cartridge, which is a tool that allows users to add milk samples to the cartridge and then place that cartridge into a Lapbox, and the last process, in which farmers will get test results in 24 hours. The company plans to use the funds raised in July 2022 to expand its business in New Zealand and Australia and launch its product into international dairy markets including the UK, EU, and the US.

Current Investors

Livestock Improvement Corporation

Request a demo to show more

Primary Industry

Agribusiness

Sub Industries

Analytics & Performance Software, Farm Equipment

Website

www.mastatest.com

Verticals

Agtech, Cloud Computing

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.